DK1307537T3 - Neospora caninum-isolat - Google Patents

Neospora caninum-isolat

Info

Publication number
DK1307537T3
DK1307537T3 DK01955123T DK01955123T DK1307537T3 DK 1307537 T3 DK1307537 T3 DK 1307537T3 DK 01955123 T DK01955123 T DK 01955123T DK 01955123 T DK01955123 T DK 01955123T DK 1307537 T3 DK1307537 T3 DK 1307537T3
Authority
DK
Denmark
Prior art keywords
neospora caninum
isolate
animals
extracts
relates
Prior art date
Application number
DK01955123T
Other languages
English (en)
Inventor
Catherine Margaret Doug Miller
Helen Elizabeth Quinn
John Timothy Ellis
Original Assignee
Univ Sydney Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sydney Tech filed Critical Univ Sydney Tech
Application granted granted Critical
Publication of DK1307537T3 publication Critical patent/DK1307537T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10Protozoa; Culture media therefor
    • C12N1/105Protozoal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/90Protozoa ; Processes using protozoa
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK01955123T 2000-07-28 2001-07-27 Neospora caninum-isolat DK1307537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ9056A AUPQ905600A0 (en) 2000-07-28 2000-07-28 Parasites
PCT/AU2001/000908 WO2002010340A1 (en) 2000-07-28 2001-07-27 $i(neospora caninum) isolate

Publications (1)

Publication Number Publication Date
DK1307537T3 true DK1307537T3 (da) 2007-09-03

Family

ID=3823114

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01955123T DK1307537T3 (da) 2000-07-28 2001-07-27 Neospora caninum-isolat

Country Status (11)

Country Link
US (3) US7361359B2 (da)
EP (1) EP1307537B1 (da)
AT (1) ATE362975T1 (da)
AU (3) AUPQ905600A0 (da)
CA (1) CA2415647A1 (da)
DE (1) DE60128569T2 (da)
DK (1) DK1307537T3 (da)
ES (1) ES2287145T3 (da)
NZ (1) NZ523697A (da)
PT (1) PT1307537E (da)
WO (2) WO2002010341A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319242B1 (es) * 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) * 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
US20100192474A1 (en) 2009-01-30 2010-08-05 Lehigh University Ultrahard stishovite nanoparticles and methods of manufacture
HUE057035T2 (hu) 2016-10-05 2022-04-28 Zoetis Services Llc Liofilizálási eljárások, amelyek stabilan dhidratált egysejtûeket eredményeznek, potens élõ vakcinaként történõ alkalmazásra

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO188396A0 (en) * 1996-08-26 1996-09-19 Insearch Limited Detection of protozoan parasites
DK0841392T3 (da) * 1996-11-12 2004-11-22 Pfizer Svækket levende Neospora vaccine
KR20010024245A (ko) 1997-10-20 2001-03-26 조지 제이. 리코스 네오스포라 백신

Also Published As

Publication number Publication date
US7361359B2 (en) 2008-04-22
AUPQ905600A0 (en) 2000-08-24
WO2002010341A1 (en) 2002-02-07
EP1307537B1 (en) 2007-05-23
ATE362975T1 (de) 2007-06-15
DE60128569T2 (de) 2008-01-31
ES2287145T3 (es) 2007-12-16
CA2415647A1 (en) 2002-02-07
DE60128569D1 (de) 2007-07-05
US20080107602A1 (en) 2008-05-08
NZ523697A (en) 2004-12-24
PT1307537E (pt) 2007-08-30
US20080107645A1 (en) 2008-05-08
AU7739001A (en) 2002-02-13
EP1307537A1 (en) 2003-05-07
US20030185852A1 (en) 2003-10-02
EP1307537A4 (en) 2005-01-05
AU2001270345A1 (en) 2002-02-13
WO2002010340A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
DE60126680D1 (de) Tragbares durchflusszytometer
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
MA27793A1 (fr) Associations de substances actives presentant des proprietes nematicides et insecticides a base de composes trifluorobutenyle
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
EP1610678A4 (en) ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF FOR INHIBITING THE ACTIVITY OF METAL PROTEINS
EP1680666A4 (en) DETECTION OF HUMAN ANTITHERAPEUTIC ANTIBODIES
BR0109002A (pt) Receptores antagonistas il-8
EP2020445A4 (en) DETECTION OF INFLAMMATORY DISEASE AND COMPOSITION FOR PREVENTING OR TREATING AN INFLAMMATORY DISEASE
TR200003252T2 (tr) Interleukın-1ß dönüştürme enzimi succınamıde inhibitörleri.
DK1307537T3 (da) Neospora caninum-isolat
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
BR0209430A (pt) Compostos heterocìclicos
BR0108867A (pt) Antagonistas de receptor il-8
ATE365036T1 (de) Creatinester-pronutrient-verbindungen und formulierungen
BR0213574A (pt) Compostos básicos lineares apresentando atividade antagonista do nk-2 e formulações contendo os mesmos
MY137266A (en) Acetylcholinesterase assay
MA28073A1 (fr) Elimination de pathogenes et de parasites vegetaux par le biais d'auxines appliquees ou induites
BRPI0411382A (pt) derivados de 2-aminobenzoil
MA27184A1 (fr) Dosage d'anticorps anti-ingap
BR0114419A (pt) N-alcoxialquil-substituìdo de benzimidazóis, sua preparação e seu uso como agentes contra protozoários parasìticos
HK1039896A1 (zh) 重組新孢子蟲抗原和它們的用途
BRPI0406802A (pt) Derivados de 9-cetoespinosinas
WO2002002087A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii